CEACAM5 and cancer: Five years later, Conry et al. developed the first mRNA cancer vaccine by showing that mice immunized with mRNA coding for carcinoembryonic antigen (CEA) mounted an anti-CEA antibody response when challenged with CEA expressing tumor cells [51].